Free Download A Machine to Make a Future: Biotech Chronicles By Paul Rabinow
2006 | 215 Pages | ISBN: 0691126143 | PDF | 8 MB
A Machine to Make a Futurerepresents a remarkably original look at the present and possible future of biotechnology research in the wake of the mapping of the human genome. The central tenet of Celera Diagnostics--the California biotech company whose formative work during 2003 is the focus of the book--is that the emergent knowledge about the genome, with its profound implications for human health, can now be turned into a powerful diagnostic apparatus--one that will yield breakthrough diagnostic and therapeutic products (and, potentially, profit). Celera's efforts--assuming they succeed--may fundamentally reshape the fabric of how health and health care are understood, practiced, and managed.Presenting a series of interviews with all of the key players in Celera Diagnostics, Paul Rabinow and Talia Dan-Cohen open a fascinating window on the complexity of corporate scientific innovation. This marks a radical departure from other books on the biotech industry by chronicling the vicissitudes of a project during a finite time period, in the words of the actors themselves.Ultimately, the authors conclude, Celera Diagnostics is engaged in a future characterized not by geniuses and their celebrated discoveries but by a largely anonymous and widely distributed profusion of data and results--a "machine to make a future."In their new afterword, Rabinow and Dan-Cohen revisit Celera Diagnostics as its mighty machine grinds along, wondering, along with the scientists, "what constitutes success and what constitutes failure?" The pathos of the situation turns on how one poses the question as much as how one answers it.

Free Download Carbonio, metabolismo, biotech. Chimica organica, biochimica e biotecnologie
Italiano | 2018 | ISBN: 8808220656 | 316 Pages | PDF | 55 MB

Biotech Juggernaut: Hope, Hype, and Hidden Agendas of Entrepreneurial BioScience By Tina Stevens, Stuart Newman
2019 | 218 Pages | ISBN: 1138043192 | PDF | 3 MB
Biotech Juggernaut: Hope, Hype, and Hidden Agendas of Entrepreneurial BioScience relates the intensifying effort of bioentrepreneurs to apply genetic engineering technologies to the human species and to extend the commercial reach of synthetic biology or "extreme genetic engineering." In 1980, legal developments concerning patenting laws transformed scientific researchers into bioentrepreneurs. Often motivated to create profit-driven biotech start-up companies or to serve on their advisory boards, university researchers now commonly operate under serious conflicts of interest. These conflicts stand in the way of giving full consideration to the social and ethical consequences of the technologies they seek to develop. Too often, bioentrepreneurs have worked to obscure how these technologies could alter human evolution and to hide the social costs of keeping on this path. Tracing the rise and cultural politics of biotechnology from a critical perspective, Biotech Juggernaut aims to correct the informational imbalance between producers of biotechnologies on the one hand, and the intended consumers of these technologies and general society, on the other. It explains how the converging vectors of economic, political, social, and cultural elements driving biotechnology's swift advance constitutes a juggernaut. It concludes with a reflection on whether it is possible for an informed public to halt what appears to be a runaway force.

Instructors: Peter Yeung | 3 sections • 11 lectures • 30m total length
Video: MP4 1280x720 44 KHz | English + Sub | Updated 1/2023 | Size: 619 MB
Crash course on biopharma CRM industry concepts
What you'll learn

Published 1/2023
MP4 | Video: h264, 1280x720 | Audio: AAC, 44.1 KHz
Language: English | Size: 689.81 MB | Duration: 0h 34m
Learn details about supporting specialty care sales and marketing that will help your career!

For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug by Nathan Vardi
English | January 10th, 2023 | ISBN: 0393540952 | 288 pages | True EPUB | 1.03 MB
A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market-and save countless lives.

Joseph Wong, "Betting on Biotech: Innovation and the Limits of Asia's Developmental State"
English | 2011 | ISBN: 0801450322 | EPUB | pages: 217 | 0.4 mb
After World War II, several late-developing countries registered astonishingly high growth rates under strong state direction, making use of smart investment strategies, turnkey factories, and reverse-engineering, and taking advantage of the postwar global economic boom. Among these economic miracles were postwar Japan and, in the 1960s and 1970s, the so-called Asian Tigers-Singapore, South Korea, and Taiwan-whose experiences epitomized the analytic category of the "developmental state."

Biotech in China: Innovation, Politics, and Economics by Rolf Schmid
English | ISBN: 9814877530 | 344 pages | EPUB | July 16, 2021 | 18 Mb
In her quest for global leadership in science and technology, the People's Republic of China has attained top ranks in the number of scientific publications, "hot papers," or national and international patent applications. However, analysis of the underlying structures and mechanisms is hindered by the sheer flood of data, stringent government control of all media, and ambiguities inherent in translation from Chinese. This book overcomes these difficulties and provides a concise picture of biotechnology-related research and development in China. It begins with brief accounts of China's geography, people, political and administrational structure, economy, finance, infrastructure related to science and technology, and educational system. It presents succinct accounts on structures and developments in biomedicine, diagnostics, agriculture, fermented food, bioindustry, and environmental biotechnology, with reference to government, industry, and academia. Finally, it predicts the next steps in Chinese biotechnology for the national agenda and, in view of China's ambitious global development strategy, the Belt and Road Initiative.